首页> 外文期刊>BMC Infectious Diseases >The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study
【24h】

The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study

机译:艾滋病毒状况和抗逆转录病毒治疗对在南非同时就诊的结核病和抗逆转录病毒治疗的新结核病患者的结核病治疗结果的影响:一项回顾性队列研究

获取原文
       

摘要

The implementation of collaborative TB-HIV services is challenging. We, therefore, assessed TB treatment outcomes in relation to HIV infection and antiretroviral therapy (ART) among TB patients attending a primary care service with co-located ART and TB clinics in Cape Town, South Africa. In this retrospective cohort study, all new TB patients aged?≥?15?years who registered and initiated TB treatment between 1 October 2009 and 30 June 2011 were identified from an electronic database. The effects of HIV-infection and ART on TB treatment outcomes were analysed using a multinomial logistic regression model, in which treatment success was the reference outcome. The 797 new TB patients included in the analysis were categorized as follows: HIV- negative, in 325 patients (40.8?%); HIV-positive on ART, in 339 patients (42.5?%) and HIV-positive not on ART, in 133 patients (16.7?%). Overall, bivariate analyses showed no significant difference in death and default rates between HIV-positive TB patients on ART and HIV-negative patients. Statistically significant higher mortality rates were found among HIV-positive patients not on ART compared to HIV-negative patients (unadjusted odds ratio (OR) 3.25; 95?% confidence interval (CI) 1.53–6.91). When multivariate analyses were conducted, the only significant difference between the patient categories on TB treatment outcomes was that HIV-positive TB patients not on ART had significantly higher mortality rates than HIV-negative patients (adjusted OR 4.12; 95?% CI 1.76–9.66). Among HIV-positive TB patients (n?=?472), 28.2?% deemed eligible did not initiate ART in spite of the co-location of TB and ART services. When multivariate analyses were restricted to HIV-positive patients in the cohort, we found that being HIV-positive not on ART was associated with higher mortality (adjusted OR 7.12; 95?% CI 2.95–18.47) and higher default rates (adjusted OR 2.27; 95?% CI 1.15–4.47). There was no significant difference in death and default rates between HIV-positive TB patients on ART and HIV negative TB patients. Despite the co-location of services 28.2?% of 472 HIV-positive TB patients deemed eligible did not initiate ART. These patients had a significantly higher death and default rates.
机译:结核病-艾滋病毒协作服务的实施具有挑战性。因此,我们评估了在南非开普敦与位于同一地点的ART和TB诊所就诊的TB患者中与HIV感染和抗逆转录病毒疗法(ART)相关的TB治疗结果。在这项回顾性队列研究中,从电子数据库中识别出所有在2009年10月1日至2011年6月30日期间登记并开始接受TB治疗的年龄≥15岁的新结核病患者。使用多项逻辑回归模型分析了艾滋病毒感染和抗病毒治疗对结核病治疗结果的影响,其中治疗成功是参考结果。分析中包括的797名新结核病患者分类如下:325名患者中HIV阴性(40.8%); 339例患者中,抗病毒治疗的HIV阳性(42.5%),133例患者中的抗病毒治疗的HIV阳性(16.7%)。总体而言,双变量分析显示,接受抗逆转录病毒治疗的HIV阳性结核病患者和HIV阴性患者的死亡率和违约率无显着差异。在未接受抗逆转录病毒治疗的艾滋病毒阳性患者中,与未感染艾滋病毒的患者相比,统计学上具有较高的死亡率(未调整比值比(OR)3.25; 95%置信区间(CI)1.53-6.91)。当进行多变量分析时,在结核治疗结果上患者类别之间的唯一显着差异是未进行抗病毒治疗的艾滋病毒阳性结核患者的死亡率显着高于艾滋病毒阴性患者(校正后的OR 4.12; 95%CI 1.76–9.66 )。在艾滋病毒呈阳性的结核病患者中(n = 472),尽管结核病和抗病毒治疗服务并存,但仍有28.2%的人认为没有开展抗病毒治疗。当多变量分析仅限于队列中的HIV阳性患者时,我们发现未接受抗逆转录病毒治疗的HIV阳性与较高的死亡率(校正后的OR为7.12; 95%CI为2.95–18.47)和较高的违约率(校正后的OR为2.27)相关。 ; 95%CI 1.15–4.47)。接受抗逆转录病毒治疗的HIV阳性结核病患者和HIV阴性结核病患者的死亡率和违约率无显着差异。尽管在同一地点提供服务,但被认为合格的472例HIV阳性结核病患者中有28.2%未发起抗逆转录病毒治疗。这些患者的死亡率和违约率明显更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号